The pathophysiology of edema formation in the nephrotic syndrome

Kidney International

Volumn 82, Issue 6, 2012, Pages 635-642

  Siddall, Eric C ^a   Radhakrishnan, Jai ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

ENaC; epithelial sodium channel; hypoalbuminemia; nephrotic syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; AMILORIDE; ANGIOTENSIN II; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; EPITHELIAL SODIUM CHANNEL; NEUROHORMONE; PLASMINOGEN; RENIN; SERINE PROTEINASE; SERUM ALBUMIN;

ADRENERGIC SYSTEM; BLOOD VESSEL PERMEABILITY; CHRONIC KIDNEY FAILURE; EDEMA; EXTRACELLULAR FLUID; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION; HEMATURIA; HUMAN; HYDROSTATIC PRESSURE; HYPOALBUMINEMIA; HYPOPROTEINEMIA; HYPOVOLEMIA; INTERSTITIAL FLUID; KIDNEY COLLECTING TUBULE; NEPHROTIC SYNDROME; NONHUMAN; ONCOTIC PRESSURE; PATHOPHYSIOLOGY; PLASMA OSMOLALITY; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RETENTION; STARLING LAW;

EID: 84865710462     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.180     Document Type: Review

References (78)

1. Taylor AE. Capillary fluid filtration. Starling forces and lymph flow. Circ Res 1981; 49: 557-575.
2. Baldwin AL, Wilson LM, Simon BR. Effect of pressure on aortic hydraulic conductance. Arterioscler Thromb 1992; 12: 163-171.
3. Knight AD, Levick JR. Effect of fluid pressure on the hydraulic conductance of interstitium and fenestrated endothelium in the rabbit knee. J Physiol 1985; 360: 311-332.
4. Perrin RM, Harper SJ, Corrall R et al. Hyperglycemia stimulates a sustained increase in hydraulic conductivity in vivo without any change in reflection coefficient. Microcirculation 2007; 14: 683-696.
5. Carter RD, Joyner WL, Renkin EM. Effects of histamine and some other substances on molecular selectivity of the capillary wall to plasma proteins and dextran. Microvasc Res 1974; 7: 31-48.
6. Joles JA. Colloid osmotic pressure in young analbuminemic rats. Am J Physiol 1989; 257: F23-F28.
7. Fiorotto M, Coward WA. Pathogenesis of oedema in protein-energy malnutrition: the significance of plasma colloid osmotic pressure. Br J Nutr 1979; 42: 21-31.
8. Koomans HA, Kortlandt W, Geers AB et al. Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery. Nephron 1985; 40: 391-395.
9. Koomans HA, Geers AB, Dorhout Mees EJ et al. Lowered tissue-fluid oncotic pressure protects the blood volume in the nephrotic syndrome. Nephron 1986; 42: 317-322.
10. Fauchald P, Noddeland H, Norseth J. Interstitial fluid volume, plasmavolume and colloid osmotic-pressure in patients with nephrotic syndrome. Scand J Clin Lab Invest 1984; 44: 661-667.
11. Russi E, Weigand K. Analbuminemia. Klin Wochenschr 1983; 61: 541-545.
12. Aukland K, Nicolaysen G. Interstitial fluid volume: local regulatory mechanisms. Physiol Rev 1981; 61: 556-643.
13. Koomans HA, Braam B, Geers AB et al. The importance of plasma protein for blood volume and blood pressure homeostasis. Kidney Int 1986; 30: 730-735.
14. Manning Jr RD, Guyton AC. Effects of hypoproteinemia on fluid volumes and arterial pressure. Am J Physiol 1983; 245: H284-H293.
15. Manning Jr RD. Effects of hypoproteinemia on renal hemodynamics, arterial pressure, and fluid volume. Am J Physiol 1987; 252(1 Pt 2): F91-F98.
16. Joles JA, Koomans HA, Kortlandt W et al. Hypoproteinemia and recovery from edema in dogs. Am J Physiol 1988; 254(6 Pt 2): F887-F894.
17. Jennette JC, Falk RJ. Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 1990; 16: 432-437.
18. Furuya R, Kumagai H, Ikegaya N et al. Reversible acute renal failure in idiopathic nephrotic syndrome. Intern Med 1993; 32: 31-35.
19. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercise. Case 4-1982. Sudden onset of renal failure and the nephrotic syndrome in a middle-aged woman. N Engl J Med 1982; 306: 221-231.
20. Conolly ME, Wrong OM, Jones NF. Reversible renal failure in idiopathic nephrotic syndrome with minimal glomerular changes. Lancet 1968; 1: 665-668.
21. Hulter HN, Bonner Jr EL. Lipoid nephrosis appearing as acute oliguric renal failure. Arch Intern Med 1980; 140: 403-405.
22. Waldman M, Crew RJ, Valeri A et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2007; 2: 445-453.
23. Meltzer JI, Keim HJ, Laragh JH et al. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 1979; 91: 688-696.
24. Geers AB, Koomans HA, Roos JC et al. Functional relationships in the nephrotic syndrome. Kidney Int 1984; 26: 324-330.
25. Geers AB, Koomans HA, Boer P et al. Plasma and blood volumes in patients with the nephrotic syndrome. Nephron 1984; 38: 170-173.
26. Geers AB, Koomans HA, Roos JC et al. Preservation of blood volume during edema removal in nephrotic subjects. Kidney Int 1985; 28: 652-657.
27. Vande Walle J, Donckerwolcke R, Boer P et al. Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int 1996; 49: 1471-1477.
28. Vande Walle JG, Donckerwolcke RA, Koomans HA. Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 1999; 10: 323-331.
29. Usberti M, Federico S, Meccariello S et al. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int 1984; 25: 422-429.
30. Usberti M, Gazzotti RM, Poiesi C et al. Considerations on the sodium retention in nephrotic syndrome. Am J Nephrol 1995; 15: 38-47.
31. Kumagai H, Onoyama K, Iseki K et al. Role of renin angiotensin aldosterone on minimal change nephrotic syndrome. Clin Nephrol 1985; 23: 229-235.
32. Brown EA, Markandu ND, Sagnella GA et al. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet 1982; 2: 1237-1240.
33. Brown EA, Markandu ND, Sagnella GA et al. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron 1984; 37: 43-48.
34. Hammond TG, Whitworth JA, Saines D et al. Renin-angiotensinaldosterone system in nephrotic syndrome. Am J Kidney Dis 1984; 4: 18-23.
35. Vande Walle JG, Donckerwolcke RA, van Isselt JW et al. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 1995; 346: 148-152.
36. Shapiro MD, Hasbargen J, Hensen J et al. Role of aldosterone in the sodium retention of patients with nephrotic syndrome. Am J Nephrol 1990; 10: 44-48.
37. Reubi FC, Weidmann P, Gluck Z. Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease. Klin Wochenschr 1979; 57: 1273-1285.
38. Oliver WJ, Owings CL. Sodium excretion in the nephrotic syndrome. Relation to serum albumin concentration, glomerular filtration rate, and aldosterone excretion rate. Am J Dis Child 1967; 113: 352-362.
39. Bohlin AB, Berg U. Renal sodium handling in minimal change nephrotic syndrome. Arch Dis Child 1984; 59: 825-830.
40. Usberti M, Gazzotti RM. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome. Am J Nephrol 1998; 18: 251-255.
41. DiBona GF. Role of the renal nerves in renal sodium retention and edema formation. Trans Am Clin Climatol Assoc 1990; 101: 38-44; discussion 44-5.
42. Pelayo JC. Renal adrenergic effector mechanisms: glomerular sites for prostaglandin interaction. Am J Physiol 1988; 254(2 Pt 2): F184-F190.
43. Rascher W, Tulassay T. Hormonal regulation of water metabolism in children with nephrotic syndrome. Kidney Int Suppl 1987; 21: S83-S89.
44. Pedersen EB, Danielsen H, Madsen M et al. Defective renal waterexcretion in nephrotic syndrome: the relationship between renal waterexcretion and kidney-function, arginine vasopressin, angiotensin-II and aldosterone in plasma before and after oral water loading. Eur J Clin Invest 1985; 15: 24-29.
45. Tulassay T, Rascher W, Lang RE et al. Atrial-natriuretic-peptide and other vasoactive hormones in nephrotic syndrome. Kidney Int 1987; 31: 1391-1395.
46. Pyo HJ, Summer SN, Niederberger M et al. Arginine-vasopressin gene-expression in rats with puromycin-induced nephrotic syndrome. Am J Kidney Dis 1995; 25: 58-62.
47. Perico N, Delaini F, Lupini C et al. Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int 1989; 36: 57-64.
48. Hildebrandt DA, Banks RO. Effect of atrial natriuretic factor on renalfunction in rats with nephrotic syndrome. Am J Physiol 1988; 254: F210-FF16.
49. Radin MJ, McCune SA. The effect of atrial-natriuretic-peptide infusion on renal hemodynamics and plasma-lipoproteins in puromycin aminonucleoside nephrosis in rats. Clin Exp Pharmacol Physiol 1993; 20: 245-251.
50. Keeler R, Feuchuk D, Wilson N. Atrial peptides and the renal response to hypervolemia in nephrotic rats. Can J Physiol Pharmacol 1987; 65: 2071-2075.
51. Valentin JP, Ying WZ, Sechi LA et al. Atrial-natriuretic-peptide and blunted renal responses to volume expansion in rats with heymann nephritis. J Hypertens 1993; 11: S218-SS19.
52. Koepke JP, DiBona GF. Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders. Am J Physiol 1987; 252(5 Pt 2): F865-F871.
53. Peterson C, Madsen B, Perlman A et al. Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans. Kidney Int 1988; 34: 825-831.
54. Ichikawa I, Rennke HG, Hoyer JR et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71: 91-103.
55. Vogt B, Favre H. Na+,K(+)-ATPase activity and hormones in single nephron segments from nephrotic rats. Clin Sci (Lond) 1991; 80: 599-604.
56. Deschenes G, Doucet A. Collecting duct (Na +K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol 2000; 11: 604-615.
57. Deschenes G, Gonin S, Zolty E et al. Increased synthesis and AVP unresponsiveness of Na,K-ATPase in collecting duct from nephrotic rats. J Am Soc Nephrol 2001; 12: 2241-2252.
58. Lourdel S, Loffing J, Favre G et al. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis. J Am Soc Nephrol 2005; 16: 3642-3650.
59. de Seigneux S, Kim SW, Hemmingsen SC et al. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome. Am J Physiol Renal Physiol 2006; 291: F208-FF17.
60. Kim SW, Wang WD, Nielsen J et al. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 2004; 286: F922-FF35.
61. Audige A, Yu ZR, Frey BM et al. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleosideinduced nephrotic syndrome. Clin Sci 2003; 104: 389-395.
62. Kim SW, de Seigneux S, Sassen MC et al. Increased apical targeting of renal ENaC subunits and decreased expression of 11 beta HSD2 in HgCl2-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 2006; 290: F674-FF87.
63. Deschenes G, Wittner M, Stefano A et al. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy. J Am Soc Nephrol 2001; 12: 598-601.
64. Snyder PM. Minireview: regulation of epithelial Na+ channel trafficking. Endocrinology 2005; 146: 5079-5085.
65. Hamm LL, Feng Z, Hering-Smith KS. Regulation of sodium transport by ENaC in the kidney. Curr Opin Nephrol Hypertens 2010; 19: 98-105.
66. Ma HP, Eaton DC. Acute regulation of epithelial sodium channel by anionic phospholipids. J Am Soc Nephrol 2005; 16: 3182-3187.
67. Hughey RP, Carattino MD, Kleyman TR. Role of proteolysis in the activation of epithelial sodium channels. Curr Opin Nephrol Hypertens 2007; 16: 444-450.
68. Carattino MD, Hughey RP, Kleyman TR. Proteolytic processing of the epithelial sodium channel gamma subunit has a dominant role in channel activation. J Biol Chem 2008; 283: 25290-25295.
69. Passero CJ, Mueller GM, Rondon-Berrios H et al. Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem 2008; 283: 36586-36591.
70. Svenningsen P, Bistrup C, Friis UG et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 2009; 20: 299-310.
71. Deschenes G, Guigonis V, Doucet A. [Molecular mechanism of edema formation in nephrotic syndrome]. Arch Pediatr 2004; 11: 1084-1094.
72. Oliver WJ. Physiologic responses associated with steroid-induced diuresis in the nephrotic syndrome. J Lab Clin Med 1963; 62: 449-464.
73. Koomans HA, Boer WH, Dorhout Mees EJ. Renal function during recovery from minimal lesions nephrotic syndrome. Nephron 1987; 47: 173-178.
74. Brown EA, Markandu N, Sagnella GA et al. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission. Nephron 1985; 39: 290-295.
75. Gamble J, Gartside IB, Christ F. A reassessment of mercury in silastic strain gauge plethysmography for microvascular permeability assessment in man. J Physiol 1993; 464: 407-422.
76. Lewis DM, Tooke JE, Beaman M et al. Peripheral microvascular parameters in the nephrotic syndrome. Kidney Int 1998; 54: 1261-1266.
77. Oqvist BW, Rippe A, Tencer J et al. In vivo microvascular clearance of albumin in renal and extrarenal tissues in puromycin aminonucleoside (PAN) induced nephrotic syndrome. Nephrol Dial Transplant 1999; 14: 1898-1903.
78. Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron 2000; 85: 194-200.